MDT · Medtronic PLC
Price
Snapshot
50 fields · last close| Market Cap | $121.2B |
| P/E | 23.16 |
| Float | 1.28B |
| Beta | 0.59 |
| Volatility | 14.6% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Low |
| Clavix score | 79.9 |
| Price | 92.94 |
| Change | −1.91% |
| Prev Close | 94.75 |
| Open | 95.83 |
| Day Low | 94.26 |
| Day High | 96.50 |
| Avg Vol | 49 |
| Avg $ Vol | $4.62B |
| 52W High | 106.33 |
| 52W Low | 73.31 |
| 52W Pos | 59.4% |
| From High | −12.59% |
| From Low | +26.78% |
| Max DD 1Y | −30.00% |
| Spread | 0.10% |
| Liquidity | Deep |
| SMA 20 | +3.79% |
| SMA 50 | +2.26% |
| SMA 200 | +5.25% |
| RSI (14) | 64.1 |
| Vol 30D | 24.0% |
| Vol 90D | 26.3% |
| 1Y Range | 73–106 |
| Daily bars | 536 |
| Perf Week | +7.09% |
| Perf Month | +2.13% |
| Perf Quarter | +13.76% |
| Perf Half Y | +9.93% |
| Perf Year | −0.62% |
| Perf YTD | −3.24% |
| Prev Day | −1.91% |
| Clavix | A- |
| Debt / Eq | 0.57 |
| Curr Ratio | 2.13 |
| Int Cover | 7.8× |
| FCF Margin | 14.9% |
| Rev Growth | +8.4% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 17 / 49 |
What MDT does
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products.
The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name.
This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments.
The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors.
Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Clavix risk grade
regraded every trading dayMDT grades A-, 79.9 of 100. Steadiest on Macro Resilience (70), most exposed on News Sentiment (54, mixed). 2 of the 4 weighted dimensions sit above the Health Care median. Ranks 17 of 49 in Health Care by Clavix score.
How rough the ride is
| MDT | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.59 | 0.84 |
| Volatilityannualized | 14.6% | 20.9% |
| Max drawdown, past yearworst peak-to-trough fall | −30.0% | — |
| Typical daily movemedian absolute daily change | 0.87% | — |
| Days beyond ±3%of the last 252 sessions | 16 (6%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| MDT | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.59 | 0.84 |
| Macro sensitivityrate, dollar and credit exposure bucket | Low | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| MDT | |
|---|---|
| 1 week | +7.1% |
| 1 month | +2.1% |
| Year to date | −3.2% |
| 1 year | −0.6% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| MDT | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 17 Sep |
| Average score0 most bearish, 100 most bullish | 68 |
| Bullish · bearisharticles above 60 · below 40 | 24 · 0 |
| Directionarticles whose tone is improving vs worsening | 24 ↑ 0 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| MDT | |
|---|---|
| Revenue growthyear over year | +8.4% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openMedtronic had two products, the Stealth AXiS surgical system and the Corsano wearable for continuous heart monitoring, named to TIME's Best Inventions of 2026 list. The article text is cut off and does not contain any financial figures or operational updates beyond the award announcement.
The article weighs whether to keep Medtronic (MDT) in a portfolio, noting the company is expanding into heart rhythm correction procedures, surgical robots, blood-pressure treatment devices, and digital surgery tools. It also flags tariffs (extra import taxes), inflation, and currency swings as risks that could shrink profit margins.
An analysis piece weighing whether to hold Medtronic stock, noting the company is expanding in cardiac ablation, robotics, hypertension treatment and digital surgery, while flagging that tariffs, inflation and currency swings are likely to squeeze profit margins.
Medtronic said it has finished separating its MiniMed diabetes business, which now trades on its own as MiniMed Group on the Nasdaq under the ticker MMED. CEO Geoff Martha commented on the team's history in diabetes care.
MiniMed has completed its separation from Medtronic (MDT) and began trading independently on Nasdaq under the ticker MMED on October 15, 2026. The announcement marks MiniMed's first day as a standalone public company.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| CVS | CVS Health Corp | A- | $118.1B | 24.16 | 0.58 | Compare |
| MCK | McKesson Corp | B+ | $117.2B | 25.51 | 0.30 | Compare |
| SYK | Stryker Corp | B | $113.0B | 30.31 | 0.79 | Compare |
| HCA | HCA Healthcare Inc | B+ | $99.34B | 14.52 | 1.12 | Compare |
| ISRG | Intuitive Surgical Inc | B- | $150.7B | 48.03 | 1.45 | Compare |
| ELV | Elevance Health Inc | B+ | $92.88B | 18.71 | 0.64 | Compare |
| ABT | Abbott Laboratories | B+ | $181.5B | 33.46 | 0.55 | Compare |
| CI | Cigna Group | A- | $79.88B | 12.45 | 0.25 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.